SYDNEY,Feb. 15,2025--Roborock,a global leader in ultra-intelligent home robotics engineered to simplify daily life,today announces the Australian launch of its newest wet-dry vacuum cleaner range,the
Feb 17, 2025
SEOUL,South Korea,Feb. 14,2025--BUYING SQUARE,a next-generation digital wholesale platform,has announced the global launch of Catalog Shop,a B2B solution designed to streamline wholesale transactions
Feb 17, 2025
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
Feb 17, 2025
The media powerhouse is taking over NBA All-Star weekend with exclusive content and star-studded experiences,showcasing a new era for digital entertainment
Feb 17, 2025
SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali
Feb 17, 2025
HONG KONG,Feb. 14,2025-- For the first time,the prestigious five-star international equestrian event with over 50 years of history in London has chosen Hong Kong as its venue,heralding the fruitful Ye
Feb 17, 2025
HONG KONG,Feb. 14,2025-- On February 14,2025,China Telecom officially announced that the capacity of the Asia Direct Cable (ADC),an international submarine cable initiative led by China Telecom,has be
Feb 17, 2025
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
Feb 17, 2025
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
Feb 17, 2025
This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights
Feb 14, 2025
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
Feb 14, 2025
BEIJING,Feb. 13,2025--Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU),a technology-driven education company and online large-class tutoring service provider in China,tod
Feb 14, 2025

© TopicFashion Privacy Policy Contact us